Treatment of age-related macular degeneration

Roland Bunting, Robyn Guymer

Research output: Contribution to journalArticleResearchpeer-review

2 Citations (Scopus)


Age-related macular degeneration is a common cause of visual loss. There may be choroidal neovascularisation or geographic atrophy. Evidence is accumulating for the importance of avoidable risk factors in age-related macular degeneration, such as smoking and obesity. Research confirms that there is an important hereditary component to the disease. Anti-vascular endothelial growth factors have improved the outlook for patients suffering from neovascular age-related macular degeneration. Recent work has concentrated on refining the frequency and pattern of delivery of these drugs to the vitreous cavity. There are few treatment options forgeographic atrophy.

Original languageEnglish
Pages (from-to)90-93
Number of pages4
JournalAustralian Prescriber
Issue number3
Publication statusPublished - 2012
Externally publishedYes


  • Anti-vascular endothelial growth factor
  • Bevacizumab
  • Choroidal neovascularisation
  • Ranibizumab

Cite this